semaglutide market size Biosimilar and Generic Size, Share and Latest Trends 2026 to 2035 Semaglutide Market Size, Share |

Filed by Novo Nordisk A/S

Key points Real-world studies show high discontinuation rates for glucagon-like peptide 1 receptor agonists (GLP1RAs) and tirzepatide, particularly among individuals without type 2 diabetes mellitus who are using these drugs to treat obesity

indefinite for others), depending on individual metabolic factors and lifestyle adherence

Liquid formulations are delivered using various devices (discussed in detail in the following section) such as catheters, droppers, squeeze bottles, metered-dose spray pumps, pressurized metered-dose inhalers, pressurized olfactory devices, nebulizers, and atomizers

Hidden costs to consider Beyond the medication and membership fees, there are a few additional costs patients sometimes overlook